You may have seen the news that the FDA is moving to restrict the large-scale compounding of semaglutide and tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro, and Zepbound. A public comment period is open through June 29, 2026, and a final decision is expected to follow.
Many of our patients have asked what this means for them. We are a plastic surgery practice, not a prescriber of these medications, so we will keep the regulatory part brief and point you to the right people for medication decisions. What we can speak to, with real depth, is the question we are uniquely qualified to answer: what a steady, well-managed weight-loss journey means for your body and your results if body contouring is part of your future.
“Policy changes around these medications can feel alarming, but for most patients the practical impact on a body contouring plan is smaller than the headlines suggest. My job is to help you make calm, informed decisions.”
— Dr. Joseph Capella
The Short Version of What Is Changing
During the medication shortages of 2022 through 2024, pharmacies were permitted to make their own compounded copies of these drugs, which is why many telehealth companies could offer them at lower prices. The FDA has since declared those shortages resolved and has proposed closing the door on large-scale compounding of these specific medications.
The brand-name medications from the manufacturers are not affected. What is being restricted are the custom-compounded copies, which the FDA has noted are not reviewed for safety, effectiveness, or quality the way approved medications are. If you take a compounded version, this is a conversation to have with your prescribing physician, not with us. They know your history and can guide you on the safest path forward.
Why Your Weight-Loss Journey Shapes Your Surgical Results
This is where our experience genuinely matters. The way you lose weight, and how steady that process is, has a direct effect on your skin, your tissue, and your ability to heal beautifully after body contouring surgery.
This is why the safety of how you lose weight is not separate from your surgical outcome. It is part of it. Rapid swings, dehydration, and inconsistent dosing all affect the body we ultimately operate on. A calm, supervised process under a physician who knows you is the best possible preparation for excellent results, whatever you and your prescriber decide about your specific medication.
What We Suggest You Do Now
- Talk to your prescriber before changing anything. Any decision about starting, stopping, or switching a GLP-1 medication belongs with the physician who prescribes it. Please do not make changes on your own.
- Know what you are taking. Ask your prescriber whether your medication is an FDA-approved brand or a compounded version, and what your options are if access changes.
- Keep a simple record of your progress. If body contouring is in your future, a clear history of your weight and your journey helps us plan the safest timing and approach.
- Plan the surgical conversation around a stable weight. The best and safest results come once your weight has held steady for several months. If your situation is changing, this is a good moment to start that conversation.
The Part That Does Not Change, Whatever the FDA Decides
Regardless of how this ruling lands, one reality remains. When significant weight comes off, many people are left with loose, excess skin that no medication, exercise, or non-surgical treatment can resolve. This is not a personal failure. It is biology, and it is the most common reason patients come to see us. We cover this in depth in our guide to the Ozempic body problem and loose skin.
That is the question we exist to help with, and it is a solved problem in experienced hands. If body contouring may be in your future, the most important decision you will make is choosing the right surgeon. Our guide on how to choose a body contouring surgeon after weight loss walks you through the five criteria that matter most. Whatever you decide about your medication, you do not have to figure out the next chapter alone.
The Bottom Line
The proposed FDA restriction targets large-scale compounded copies of semaglutide and tirzepatide, not the brand-name medications, and any decision about your medication belongs with your prescriber. What does not change is the effect your weight-loss journey has on your body. A steady, supervised process supports your skin, your tissue, and your ability to heal, and loose, excess skin after significant weight loss is biology, not a personal failure. If body contouring is in your future, plan that conversation around a stable weight and choose your surgeon carefully.
Ready to Talk About Your Body Contouring Options?
Whatever you decide about medication, our team at Capella Plastic Surgery is here when you are ready to plan the next chapter. Learn more about our post-weight loss body contouring procedures, review our financing information, or to schedule a consultation, please contact us.
About Dr. Capella
Dr. Joseph F. Capella is a board-certified plastic surgeon, and a pioneer and world leader in body contouring after weight loss. He completed his plastic surgery fellowship at the Mayo Clinic, serves as Chief of the Division of Post-Bariatric Surgery at Hackensack University Medical Center, and is Chief of Plastic Surgery at Pascack Valley Medical Center. He has devoted his entire 25-year career to a single focus: caring for patients after major weight loss. It is not one of the things he does. It is the only thing he does.
He has cared for more than 25,000 patients and performed over 15,000 procedures, and he holds the largest published single-surgeon case series in the world on body lifts, arm lifts, and medial thigh lifts. He has been named one of the Top 10 Plastic Surgeons in New York and recognized among the Best Doctors in America for four consecutive years. His work has been featured on ABC’s 20/20, The View, CNBC, and Elle, and he is frequently the surgeon to whom other surgeons refer their post-weight-loss patients. His father, Dr. Rafael Capella, was a founding member of the American Society for Metabolic and Bariatric Surgery.
Frequently Asked Questions
What is the FDA changing about compounded semaglutide and tirzepatide?
The FDA is moving to restrict large-scale compounding of semaglutide and tirzepatide, the active ingredients in Ozempic, Wegovy, Mounjaro, and Zepbound. Pharmacies were permitted to make compounded copies during the shortages of 2022 through 2024, which the FDA has since declared resolved. A public comment period is open through June 29, 2026, and a final decision is expected to follow.
Are brand-name Ozempic and Wegovy affected by the compounding restriction?
The brand-name medications from the manufacturers are not affected. What is being restricted are the custom-compounded copies, which the FDA has noted are not reviewed for safety, effectiveness, or quality the way approved medications are. If you take a compounded version, that is a conversation to have with your prescribing physician.
Who should I talk to before changing my GLP-1 medication?
Any decision about starting, stopping, or switching a GLP-1 medication belongs with the physician who prescribes it. Capella Plastic Surgery is a plastic surgery practice, not a prescriber of these medications. Your prescriber knows your history, can tell you whether you take an FDA-approved brand or a compounded version, and can explain your options if access changes.
How does the way I lose weight affect body contouring results?
The way you lose weight, and how steady that process is, has a direct effect on your skin, your tissue, and your ability to heal after body contouring surgery. Rapid swings, dehydration, and inconsistent dosing all affect the body that is ultimately operated on, so a calm, supervised process is the best preparation for excellent results.
When should I plan body contouring after GLP-1 weight loss?
The best and safest results come once your weight has held steady for several months. A simple record of your weight and your journey helps Dr. Capella plan the safest timing and approach. If your situation is changing, this can be a good moment to start that conversation, even before your weight has fully settled.
Editor’s note: Information on the FDA proposal is current as of June 2026 and reflects a proposed rule open for public comment through June 29, 2026. A final determination had not been issued at the time of writing.
This article is general educational information and is not medical advice. Always consult your own physician before making decisions about medication or surgery.
